SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Vascular Closure Systems, Inc. Announces 30-Day Follow-Up Results for Phase I of the First in Human (FIH) Clinical Use, of the FastSeal® Bioabsorbable Vascular Access Closure System